In this video, analyst Andrew Tonner talks about Apple's earnings report, which is due next week. The story is certainly the most important in the tech sector, as Apple's stock has been crashing this year.
Andrew focuses on Apple's dividend policy from the upcoming earnings report, as the company is expected to raise its payout on Tuesday. That would not only get investors the return they were waiting for, but it's also likely to improve Apple's share price. Apple's sitting on a $137 billion cash pile and can easily fund a significant dividend increase.
Apple CEO Tim Cook said the company has been looking at various policies for investors, including an issue of�preferential shares. Andrew says it's important not just for Apple to take this step, but to do it on Tuesday.
Hot Wireless Telecom Companies To Invest In 2014: Washington Real Estate Investment Trust(WRE)
Washington Real Estate Investment Trust is an equity real estate investment trust (REIT). The company engages in the ownership, operation, and development of real properties. The firm invests in real estate markets of the greater Washington D.C. metro region. It focuses on office, medical office, industrial/flex space, retail, and multifamily real estate investments. Washington Real Estate Investment Trust was founded in 1960 and is based in Rockville, Maryland.
Hot Wireless Telecom Companies To Invest In 2014: SciClone Pharmaceuticals Inc.(SCLN)
SciClone Pharmaceuticals, Inc. engages in the development and commercialization of novel therapeutics for the treatment of oncology, infectious diseases, cardiovascular, urological, respiratory, and central nervous system disorders in the People?s Republic of China and internationally. Its principal product is ZADAXIN for the treatment of hepatitis B and hepatitis C viruses, and certain cancers, as well as for use as a vaccine adjuvant or as a chemotherapy adjuvant for cancer patients with weakened immune systems. ZADAXIN has approval in approximately 30 countries, primarily China, the Pacific Rim, Latin America, eastern Europe, and the Middle East. The company markets and sells ZADAXIN principally through its distributors. It is also developing SCV-07, which is in Phase 2 clinical trials for the treatment of oral mucositis and hepatitis C virus. In addition, the company markets partnered products in China, including Depakine, an anti-convulsant; Tritace, an ACE inhibitor for the treatment of hypertension; Stilnox, a hypnotic for the short-term treatment of insomnia; and Aggrastat, a cardiology product. SciClone Pharmaceuticals also has commercialization rights for DC Bead, a product candidate for the treatment of advanced liver cancer in China, as well as for ondansetron RapidFilm, an oral thin film formulation of ondansetron to treat and prevent nausea and vomiting caused by chemotherapy, radiotherapy, and surgery in China and Vietnam. The company was founded in 1989 and is headquartered in Foster City, California.
Hot Rising Companies To Own For 2014: Malvern Federal Bancorp Inc.(MLVF)
Malvern Federal Bancorp, Inc. operates as the bank holding company for Malvern Federal Savings Bank, which is a federally chartered savings bank. It provides banking services in Pennsylvania. The company engages in attracting deposits from the general public and using those funds to invest in loans and investment securities. Its deposit products include interest-bearing and non-interest-bearing checking accounts, as well as money market, savings, and certificate of deposit accounts. The company?s loan products principally include one-to four family residential mortgage loans; and consumer loans comprising home equity loans, home equity lines of credit, automobile loans, unsecured personal loans, and loans secured by deposits. It conducts business from its headquarters and eight full-service branches in Chester and Delaware Counties, Pennsylvania. The company was founded in 1887 and is headquartered in Paoli, Pennsylvania.
Hot Wireless Telecom Companies To Invest In 2014: Transcept Pharmaceuticals Inc.(TSPT)
Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of proprietary products that address therapeutic needs in the field of neuroscience. Its principal product is the Intermezzo, a low dose sublingual formulation of zolpidem as a sleep aid for use in the middle of the night at the time a patient awakens and has difficulty returning to sleep. The company has a collaboration agreement with Purdue Pharmaceutical Products, L.P. for the commercialization of Intermezzo in the United States. It is also developing TO-2061, a low dose ondansetron adjunctive therapy, which is in Phase II study for patients with obsessive-compulsive disorder. The company was founded in 2002 and is based in Point Richmond, California.
Advisors' Opinion:- [By Michael J. Ray]
The next company and their handle go together quite well. TSPT is a specialty pharmaceutical company, focused on the development and commercialization of proprietary products that address therapeutic needs in the field of neuroscience. The principal product is Intermezzo, which is a sleep aid used in the middle of the night at the time a patient awakens and has difficulty returning to sleep.
The company has not always been a sleeper by any means. As TSPT tried to get the drug past the initial FDA review in July it was met with a rejection letter. In the ensuing fallout the stock price fell over 70% and traded around the $3 range. But in November of 2011 the U.S. Food and Drug Administration (FDA) approved Intermezzo, and TSPT finally cleared their first hurdle for their drug. The stock price currently trades around $8 a share, so it has not recovered from the high of $11 to $12 range that it made in the past.
In more recent news, TSPT announced in December of 2011 that it had received a $10 million milestone payment from Purdue Pharma L.P. in connection with the listing of Intermezzo in the FDA Orange Book. The milestone payment was made under the terms of the agreement between Purdue and Transcept for the commercialization of Intermezzo in the United States. Purdue has plans to launch Intermezzo in the second quarter of 2012 and to invest approximately $100 million to support sales and marketing during the first year of commercialization.
So other than being in the “sleep business”, why is this stock’s handle known as the sleeper? The answer to that comes from the actual drug’s intended use. Intermezzo is used for the treatment of insomnia when a middle-of-the-night awakening is followed by difficulty returning to sleep. Middle-of-the-night awakening with difficulty falling back to sleep is a common sleep problem, and this drug is the only prescription sleep aid approved for this type of insomnia. The issue is how to value a new drug like this. Analysts! have very different takes on how the final outcome will play out dealing with demand and sales. Some believe that Intermezzo will run into serious competition from big players and products like Ambien by Sanofi (SNY), Lunesta by Sunovion, Sonata from Pfizer. Others have a different take in that they see the demand for the drug will be high as it can be taken as needed, rather than falling into an automated regiment of taking a daily sleep aid based only on anticipated need.
Until this debate finally gets settled by actual sales figures and trending analysis, the stock might remain a sleeper for a bit. If the medical community receives the drug with open arm, then demand could be very high which would propel the stock price to new heights. As Purdue starts to invest their money in 2012, it should start increase awareness and hopefully the stock price.
Hot Wireless Telecom Companies To Invest In 2014: Williams Partners L.P.(WPZ)
Williams Partners L.P. focuses on natural gas transportation, gathering, treating and processing, storage, natural gas liquid fractionation, and oil transportation activities in the United States. The company operates in two segments, Gas Pipeline, and Midstream Gas and Liquids. The Gas Pipeline segment owns and operates approximately 13,900 miles of pipelines with annual throughput of approximately 2,700 trillion British thermal units of natural gas and delivery capacity of approximately 13 million dekatherms of gas. This segment also owns interests in joint venture interstate and intrastate natural gas pipeline systems. The Midstream Gas and Liquids segment includes natural gas gathering, processing, and treating facilities; and crude oil gathering and transportation facilities that serve the producing basins in Colorado, New Mexico, Wyoming, the Gulf of Mexico, and Pennsylvania. Williams Partners GP LLC serves as the general partner of the company. Williams Partners L.P . was founded in 2005 and is based in Tulsa, Oklahoma.
Advisors' Opinion:- [By Louis Navellier]
Williams Partners (NYSE:WPZ) is an integrated natural gas company that is involved with exploration and production, midstream gathering and processing and interstate natural gas transportation. In the last nine-and-a-half months, WPZ stock has gained 18% since January 2011.
Hot Wireless Telecom Companies To Invest In 2014: Tempur-pedic International Inc (TPX)
Tempur-Pedic International Inc. manufactures, markets, and distributes bedding products in North America and internationally. Its products include pillows, mattresses, and adjustable beds, as well as various cushions and other comfort products. The company sells its mattresses and pillows under the TEMPUR and Tempur-Pedic brand names through furniture and bedding, specialty, and department stores; direct response, Internet, and own stores; chiropractors, medical retailers, hospitals, and other healthcare markets; and third party distributors. Tempur-Pedic International Inc. was founded in 1989 and is based in Lexington, Kentucky.
No comments:
Post a Comment